SEC Form 4 · accession 0000899243-19-000539
Tectonic Therapeutic, Inc. · TECX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erik Ostrowski
Officer — Chief Financial Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2019 | A | 2,300 | $0.00 | A | 2,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $15.65 | Jan 2, 2019 | A | 186,000 | A | — | Jan 1, 2029 | Common Stock | 186,000 | 186,000 | D |
Explanation of responses
- F1The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of AVROBIO, Inc., common stock. The restricted stock units vest as follows: 25% of the shares vest on January 2, 2020, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.
- F225% of the shares vest on January 2, 2020, and the remaining 75% shall vest in equal monthly installments thereafter over a three-year period.